Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

Background: The prognosis of early stage non-small cell lung cancer (NSCLC) is quite disappointing and the benefits of adjuvant therapy are relatively small. Thus, there is an urgent need to identify novel prognostic and predictive biomarkers. Lung adenocarcinoma has distinct clinical–pathological c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: de Miguel-Pérez, Diego, Bayarri-Lara, Clara Isabel, Ortega, Francisco Gabriel, Russo, Alessandro, Moyano Rodriguez, María José, Alvarez-Cubero, Maria Jesus, Maza Serrano, Elizabeth, Lorente, José Antonio, Rolfo, Christian, Serrano, María José
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896005/
https://ncbi.nlm.nih.gov/pubmed/31703465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11111750
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars